Affiliation:
1. Department of Medical Statistics, School of Public Health Sun Yat‐sen University Guangzhou China
2. Center for Migrant Health Policy Sun Yat‐sen University Guangzhou China
Abstract
ABSTRACTHypothetical strategy is a common strategy for handling intercurrent events (IEs). No current guideline or study considers treatment–IE interaction to target the estimand in any one IE‐handling strategy. Based on the hypothetical strategy, we aimed to (1) assess the performance of three estimators with different considerations for the treatment–IE interaction in a simulation and (2) compare the estimation of these estimators in a real trial. Simulation data were generalized based on realistic clinical trials of Alzheimer's disease. The estimand of interest was the effect of treatment with no IE occurring under the hypothetical strategy. Three estimators, namely, G‐estimation with and without interaction and IE‐ignored estimation, were compared in scenarios where the treatment–IE interaction effect was set as −50% to 50% of the main effect. Bias was the key performance measure. The real case was derived from a randomized trial of methadone maintenance treatment. Only G‐estimation with interaction exhibited unbiased estimations regardless of the existence, direction or magnitude of the treatment–IE interaction in those scenarios. Neglecting the interaction and ignoring the IE would introduce a bias as large as 0.093 and 0.241 (true value, −1.561) if the interaction effect existed. In the real case, compared with G‐estimation with interaction, G‐estimation without interaction and IE‐ignored estimation increased the estimand of interest by 33.55% and 34.36%, respectively. This study highlights the importance of considering treatment–IE interaction in the estimand framework. In practice, it would be better to include the interaction in the estimator by default.
Funder
Natural Science Foundation of Guangdong Province
National Natural Science Foundation of China
Reference38 articles.
1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use “Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials ”(2019).
2. Evaluating How Clear the Questions Being Investigated in Randomised Trials Are: Systematic Review of Estimands;Cro S.;BMJ,2022
3. Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods;Parra C. O.;Statistics in Biopharmaceutical Research,2023
4. Choice of Estimand and Analysis Methods in Diabetes Trials With Rescue Medication;Holzhauer B.;Pharmaceutical Statistics,2015
5. Adverse Drug Reactions as Cause of Admission to Hospital: Prospective Analysis of 18 820 Patients;Pirmohamed M.;BMJ,2004